Management of a large tumour

H. Ris (Lausanne, Switzerland)

Source: Annual Congress 2005 - Oncology Grand Round: an interactive session
Session: Oncology Grand Round: an interactive session
Session type: Major Symposium
Number: 1287
Disease area: Thoracic oncology

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Ris (Lausanne, Switzerland). Management of a large tumour. Annual Congress 2005 - Oncology Grand Round: an interactive session

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Utility of 18 FDG-PET scan in stage 1a non small cell lung cancer (NSCLC)
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009


Staging and restaging in the era of multimodality treatment
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Lung cancer
Source: Respipedia Article
Year: 2018

Should there be a specific management for large cell neuroendocrine carcinoma?
Source: Annual Congress 2005 - Neuroendocrine tumours of the lung
Year: 2005

Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation
Source: Eur Respir J 2011; 37: 624-631
Year: 2011



Correlatin between PET scan and cytokine in non-small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012


Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012



Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma
Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma
Year: 2006


Biological factors predicting response to chemotherapy (CT) in advanced non small cell lung cancer (NSCLC): A feasibility study on the collection of tissue
Source: Annual Congress 2010 - The role of biomarkers in lung cancer
Year: 2010

Extrathoracic 18-FDG-PET uptakes in non small cell lung cancer (NSCLC) preoperative staging
Source: Eur Respir J 2007; 30: Suppl. 51, 430s
Year: 2007

A novel biologic classification of non-small cell lung cancer
Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology
Year: 2005


Tumor-derived tumor necrosis factor-α promotes Lewis lung cancer-induced malignant pleural effusions in mice
Source: Annual Congress 2006 - Molecular pathology and genetics of lung cancer
Year: 2006


Management of bone metastases (BM): results of a large multinational, multidisciplinary survey
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Surgical multimodality treatment for stage III non-small cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Long time survival after resection for multiple primary lung cancers. A population-based study
Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology
Year: 2005


Radiotherapy of nonsmall and small cell lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=190
Year: 2001

Preoperative FDG uptake on PET/CT predicts disease recurrence and survival in early stage non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016


Staging of lung cancer
Source: Eur Respir Mon; 2009: 44: 150–168
Year: 2009